Drugplain

COSYNTROPIN .25 mg/mL

COSYNTROPIN · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · HF Acquisition Co LLC, DBA HealthFirst

1 Recall on Record
Plain English

COSYNTROPIN is a injection, powder, lyophilized, for solution containing cosyntropin at .25 mg/mL, taken intravenous. Manufactured by HF Acquisition Co LLC, DBA HealthFirst.

Key Facts

Brand Name
COSYNTROPIN
Generic Name
COSYNTROPIN
NDC Code (Product)
51662-1567
Manufacturer
HF Acquisition Co LLC, DBA HealthFirst
Strength
.25 mg/mL
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Marketing Status
Application #
ANDA202147
Drug Class
Adrenocorticotropic Hormone [EPC]
Marketing Start
07/10/2021

Recall History

1 Recall on Record
Class II05/21/2012

Franck's Lab Inc., d.b.a. Franck's Compounding Lab

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

TerminatedVoluntary: Firm initiated

Frequently Asked Questions

What is COSYNTROPIN used for?

COSYNTROPIN contains COSYNTROPIN. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.

Is COSYNTROPIN a controlled substance?

COSYNTROPIN is not classified as a controlled substance by the DEA.

What is the generic name for COSYNTROPIN?

The generic name for COSYNTROPIN is COSYNTROPIN. There are 4 other brand versions of COSYNTROPIN.

What is the NDC code for COSYNTROPIN .25 mg/mL?

The NDC (National Drug Code) for COSYNTROPIN .25 mg/mL is 51662-1567, listed by HF Acquisition Co LLC, DBA HealthFirst.

Product NDC

51662-1567

Package NDC

51662-1567-1

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)